September 20, 2021
A New Jersey federal judge on Monday found that Sandoz and Zydus Pharmaceuticals infringed several of Amgen's patents for its blockbuster plaque psoriasis medication Otezla, entering judgment in favor of Amgen on a trio of patents.
July 28, 2021
Amgen Inc. urged a New Jersey federal court on Wednesday to find that Sandoz Inc. and Zydus Pharmaceuticals Inc. infringed patents for the blockbuster plaque psoriasis medication Otezla, wrapping up a trial in which the generic-drug makers said the formulas were too obvious to warrant patent protection.